<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05799768</url>
  </required_header>
  <id_info>
    <org_study_id>2020H0090</org_study_id>
    <nct_id>NCT05799768</nct_id>
  </id_info>
  <brief_title>Ketogenic Diet in Rheumatoid Arthritis (RA)</brief_title>
  <acronym>KETORA</acronym>
  <official_title>Ketogenic Diet Intervention in Patients With Rheumatoid Arthritis (RA): a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rheumatology Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 6-week ketogenic diet (KD) intervention where participants with rheumatoid&#xD;
      arthritis (RA) will follow a KD plan, supervised and monitored by a dietician. Participants&#xD;
      will be provided extensive educational and ongoing support on the KD, including personalized&#xD;
      coaching with the ability to text a dietitian at any time and expect a response within 12&#xD;
      hours. Diet adherence and progress will be assessed daily using at-home blood ketone/glucose&#xD;
      monitors, along with diet records. Participants will fill out health related questionnaires&#xD;
      and undergo assessments of body composition, RA disease activity. This study also includes&#xD;
      blood draws and fat biopsy of the abdominal region.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">April 15, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hsCRP</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>DAS28-CRP</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Inflammation</condition>
  <condition>Obesity</condition>
  <condition>Ketogenic Dieting</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Ketogenic diet plan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be provided extensive educational and ongoing support on the KD, including personalized coaching with the ability to text a dietitian at any time and expect a response within 12 hours. Diet adherence and progress will be assessed daily using at-home whole capillary blood ketone/glucose monitors, along with diet records. We will assess adherence based on days in ketosis following these parameters: (BHB ≥ 0.5mM). Adherence will be defined as &gt; 80% of days in ketosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ketogenic diet</intervention_name>
    <description>Ketogenic diet counseling</description>
    <arm_group_label>Ketogenic diet plan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of RA according to the ACR/EULAR 2010 criteria for RA.&#xD;
&#xD;
          -  On stable doses of DMARDs and/ or biological agents (≥ 2 months prior to study&#xD;
             enrollment)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic inflammatory/ autoimmune disease other than RA (e.g. gout, inflammatory bowel&#xD;
             disease such as Crohn's disease or ulcerative colitis, lupus, myositis, etc.)&#xD;
&#xD;
          -  Prednisone or other glucocorticoid use in the last 4 weeks (exception: intra-articular&#xD;
             glucocorticoid injections)&#xD;
&#xD;
          -  Insulin use&#xD;
&#xD;
          -  Hospitalization in the 30 days prior to study enrollment&#xD;
&#xD;
          -  Acute or uncontrolled disease (e.g. cirrhosis, COPD, CKD)&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Chronic infection (HIV, hep B/C, etc.)&#xD;
&#xD;
          -  Heavy drinking&#xD;
&#xD;
          -  On a ketogenic diet or exogenous ketone supplement (lses than 3 months prior to study&#xD;
             enrollment)&#xD;
&#xD;
          -  Recent weight loss (&gt;5% in the last 2 months)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 23, 2023</study_first_submitted>
  <study_first_submitted_qc>March 23, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2023</study_first_posted>
  <last_update_submitted>March 23, 2023</last_update_submitted>
  <last_update_submitted_qc>March 23, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Beatriz Hanaoka</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

